Wegovy Pill vs Saxenda: Full Comparison

Saxenda was among the first GLP-1 medications approved for weight management, and it's still prescribed today. It delivers liraglutide — an earlier-generation GLP-1 — as a daily injection. Wegovy pills deliver semaglutide, a longer-acting successor, as a daily tablet. Same class, one generation and one needle apart.

Liraglutide vs semaglutide

Both molecules activate GLP-1 receptors to curb appetite and slow digestion. Semaglutide's structure lets it act far longer in the body, which translates into stronger and steadier appetite control at approved doses. In head-to-head research, semaglutide consistently produced greater weight loss than liraglutide — one of the clearer within-class comparisons in the literature.

The numbers

Saxenda's trials showed average losses in the range of 5–8% of body weight over about a year. Oral semaglutide's 64-week study averaged 14% (~33 lb), with 1 in 4 participants losing 20% or more — roughly double the typical Saxenda outcome. For patients who tried Saxenda years ago with modest results, the newer generation is often a genuinely different experience.

Daily shot vs daily tablet

Here the comparison gets stark: Saxenda isn't even a weekly injection — it's every single day, 365 needles a year, plus refrigeration and sharps disposal. Wegovy pills ask for one swallowed tablet each morning on an empty stomach (routine details here). If daily frequency is happening either way, most people would rather it be a pill.

Side effects and cost

Both share GLP-1 digestive side effects — nausea most prominently, typically fading with titration — and both require doctor screening for contraindications (see our side effects guide). Saxenda's list price historically ran $1,300+ monthly with inconsistent coverage. Wegovy pills: from $149/month self-pay, no insurance needed, charged only after approval.

Verdict

Saxenda earned its place historically, but on today's menu it's hard to recommend over semaglutide for most patients: roughly half the average weight loss, daily needles, and a higher price. If you're weighing the two, a free online consultation with a licensed doctor settles it against your actual health history — with a Wegovy pills prescription issued in 10–15 minutes if you're approved.

Why Saxenda still gets prescribed

Fairness demands the counterpoint: Saxenda retains legitimate uses. Liraglutide has a long safety track record, an approval for adolescents that some newer options lacked, and familiarity among prescribers who've used it for a decade. A minority of patients also tolerate liraglutide better than semaglutide, and for them the older molecule is the right call. But those are exceptions a doctor identifies — not reasons for a typical adult starting fresh in 2026 to accept half the average results with seven times the weekly needle count.

Transitioning off Saxenda

If you're currently on Saxenda with modest results, don't quit cold to try something new — GLP-1 transitions work best as a planned handoff. A licensed doctor reviews your liraglutide dose and response, times the switch, and starts your semaglutide titration at the appropriate rung so appetite control carries through the changeover. That review is exactly what a free online consultation covers; if the switch to Wegovy pills is approved, your prescription is issued in 10–15 minutes and your plan (from $149/month) includes the follow-up check-ins the transition needs.

The broader lesson of the Saxenda era still holds today: this field improves fast, and being on an effective, sustainable therapy now beats waiting for a perfect one later. Start with the best current fit for your body and budget, and let your doctor evolve the plan as options do.